In his blog, he wrote "while the statement 'if it ain't broke, don't fix it' serves as a great warning whenever we contemplate something new, it should not mean that we ignore the options. A good case in point is the way we currently analyze and visualize discovery and development data. The tried and true tools include SAS, S-PLUS, Spotfire and Integrated Review. But now there is another tool that's worth a look, Tableau."
We always are grateful when people see that what Tableau is doing is different and innovative. And in fact, George saw that we have plenty of Biopharma clients (including Pfizer, Johnson & Johnson, Roche Diagnostics, Merck, etc.) so we're really not a stretch for this industry.